This U.S. industry comprises establishments primarily engaged in manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except diagnostic).
Agar culture media manufacturing
Aggressins (except in-vitro) manufacturing
Allergenic extracts (except diagnostic substances) manufacturing
Allergens manufacturing
Antigens manufacturing
Antiserums manufacturing
Antitoxins manufacturing
Antivenoms manufacturing
Bacterial vaccines manufacturing
Bacterins (i.e., bacterial vaccines) manufacturing
Blood derivatives manufacturing
Blood fractions manufacturing
Cholera serums manufacturing
Culture media manufacturing
Gene therapy preparations manufacturing
Hematology products (except diagnostic substances) manufacturing
Plasmas manufacturing
Serums (except diagnostic substances) manufacturing
Toxoids (e.g., diphtheria, tetanus) manufacturing
Tuberculin (i.e., tuberculo-protein derived) manufacturing
Vaccines (i.e., bacterial, virus) manufacturing
Virus vaccines manufacturing
A review and comparison of financial performance of privately-help companies in specified SIC/NAICS industry segment, using industry standard benchmarks.
Answeres comes easily with Industrius CFO. Review ROI, sales per employee, profit margins of the top 10%, top 25% and more, to identify areas of concern and opportunity. Examine “what if scenarios and P&L impact of reducing costs or adding revenue.
It takes only five minutes to enter your data and produce a concise profile of your company’s fiscal state, including critical business ratios focusing on liquidity, profitability, asset efficiency, and growth.